Clinical Problems in the Diagnosis and Treatment of PCOS During Adolescence

Size: px
Start display at page:

Download "Clinical Problems in the Diagnosis and Treatment of PCOS During Adolescence"

Transcription

1 Clinical Problems in the Diagnosis and Treatment of PCOS During Adolescence R a c h a n a S h a h, M D M S T A s s i s t a n t P r o f e s s o r o f P e d i a t r i c s D i v i s i o n o f E n d o c r i n o l o g y a n d D i a b e t e s

2 Disclosures Off-label use of metformin in treatment of PCOS

3 OBJECTIVES Understand clinical presentation of PCOS in teens Describe the diagnostic work-up of PCOS in teenagers Understand short and long-term consequences of PCOS in teens Discuss treatment options for PCOS in teenagers

4 Case: 15 year old Menarche at 12. periods initially regular but this year has only had 4 periods Acne on face, using topical treatments; worse this year Some hair on upper lip, lower back, began at menarche Feeling anxious about school, hanging out less with friends No family history of similar Has gained 10 lbs past year, stopped playing basketball, snacking more BMI 85 th percentile. Exam normal except: flat affect, acne & mild hirsutism face, lower back

5 Questions Is this normal? Should it be evaluated? How? How can we counsel her, regardless of diagnosis?

6 PCOS in Adolescents Under diagnosed in teens, especially lean Symptoms may mimic normal puberty Weight gain Insulin resistance Irregular periods Acne Disease is often EVOLVING and girl may not meet diagnostic criteria YET or may have features of PCOS that resolve with time

7 Diagnostic Challenges Laboratory references for ADULT women Must rule out other conditions (adrenal disorders, tumors) May never have period Ultrasound findings not usually helpful PCOS-like ovaries seen in other diseases Criteria based on transvaginal ultrasounds Ovarian size/shape/cysts are different in teens Larger ovaries with more cysts may be NORMAL Need to establish age-based criteria

8 Diagnostic Challenges Symptoms of PCOS are evolving and may not be readily apparent in adolescents Because the diagnosis has significant lifelong implications including testing, treatments, and related anxiety, diagnosis is made with caution When diagnosis unclear, recommend: Education Treatment of specific symptoms if needed Follow up

9 Dermatologic Issues Hirsutism terminal hair in MALE pattern Does NOT correlate with androgen levels but with IR Found in 69% of PCOS teens Racial/ethnic differences important Acne more severe (cystic, not responding to topical treatments), different pattern (JAWLINE, back, chest), worse with periods Less specific, as 2/3 of normal teens have acne Androgenic alopecia: Scalp hair thinning in male pattern Much less common, incidence not reported Skin issues cause embarrassment, poor self-esteem

10 Hirsutism Scoring (modified Ferriman Gallwey)

11 Modified Ferriman Gallwey Rate 0-4 on 9 body areas >6-8=hirsutism in Caucasian and African American Suggested cut-off of 4 in East Asian Proposed higher cut-off in Middle Eastern/Southeast Indian and other populations Mostly helpful as a baseline and to follow effect of treatment

12 Anovulatory Cycles Can have regular periods (10-15%), increased frequency, heavy bleeding Oligomenorrhea (infrequent periods): >35 day cycles (45 in teens) or <9/year (8 in teens) Amenorrhea primary or secondary (>90 day interval) Risk of endometrial hyperplasia & uterine cancer Degree of menstrual dysfunction correlates with IR

13 The Menstrual Cycle as a Vital Sign POPULATION NORMS IN THE US Menarche (median age): years Mean cycle interval: 32.2 days in first gynecologic year Menstrual cycle interval: typically days Menstrual flow length: 7 days Menstrual product use: 3 6 pads/tampons per day ASK at well child visits and offer anticipatory guidance EVALUATE if the girl s cycles are outside these norms

14 PCOS is a Cardiometabolic Risk Factor EVEN IF NOT OBESE more likely to have: Endothelial dysfunction, increased carotid IMT & CAC Markers of chronic systemic inflammation Diseases with cardiometabolic risks Metabolic Syndrome (35% in adolescent cohorts!) Type 2 diabetes, insulin resistance Hyperlipidemia Hypertension Sleep apnea Fatty liver

15 Psychiatric Risk in PCOS Increased depression and anxiety Adult study: 35% met criteria for depression (vs 7% control population) 45% with anxiety (vs 18% control) Depression associated with BMI and insulin resistance Disordered eating (binge-eating, bulimia) more common Poor body image due to: weight, hirsutism, acne, and fertility concerns SCREEN AND REFER!! Hormonal treatment and even nutrition advice can exacerbate

16 Differential Diagnosis Normal puberty Idiopathic hirsutism (15-30%) Non-classical congenital adrenal hyperplasia (3%) Androgen-secreting adrenal/ovarian tumor Exogenous androgen exposure Cushing s syndrome Hypothyroidism Prolactinoma Other DSD: androgen-insensitivity, gonadal dysgenesis, 17-beta HSD deficiency

17 Risk Factors for PCOS Premature adrenarche Low birth weight (SGA, IUGR) Prenatal androgen exposure Genetics (Explain a very small % of heritability) gonadotropin receptor: LHCGR and FSHR, cytoplasmic function glucose homeostasis: PPARgamma, IRS-1 androgen signaling: AR

18 Diagnostic Criteria NIH, 1990 Rotterdam, 2003 (endorsed by Endo society, 2013) 2 of 3 Hyperandrogenism x x x Oligoovulation x x x or PCOM x x AE-PCOS, 2006 Hyperandrogenism + one other other entities are excluded that would cause excess androgen activity

19 Diagnosis in Adolescence Witchel, et al Hyperandrogenism moderate/severe hirsutism=hyperandrogenism Moderate/severe acne NOT responding to topical should be worked up Persistent elevation of total or free testosterone (cut off assay specific) Oligoovulation <21 days or >45 days (once 2 years post-menarche) >90 days any time Amenorrhea by age 15 or 3 years post thelarche No good data to define PCOM in adolescents, do not use US for dx

20 Laboratory Tests Diagnostic for PCOS: Increased bioactive T Testosterone profile total testosterone: HIGH or normal sex hormone binding globulin: LOW free testosterone: HIGH DHEAS elevated in about 35%, but only 5% with only DHEAS and no T elevation Measure T by LC/MS/MS in AM

21 Laboratory Tests, cont. Rule out other causes Pregnancy Thyroid prolactin 17-hydroxyprogesterone(CAH) LH, FSH Bleeding disorders (if heavy/frequent) Other, as indicated (cortisol, other adrenal androgens) Comorbidities Glucose, hemoglobin A1c, insulin (consider OGTT) Fasting lipid profile Liver enzymes

22 When to Ultrasound? Signs/symptoms of androgen-secreting tumor Marked testosterone elevation (>200) Rapid onset of virilization cliteromegaly/voice deepening Evaluate anatomy Primary amenorrhea Pain or palpable mass in pelvis

23 Adult Criteria for PCOS morphology on ultrasound (transvaginal) Increased ovarian volume >10 cm 3 for one or both ovaries -or- Multiple cysts Counting both ovaries, at least cysts between 2 and 9 mm (changed to reflect more sensitive methods!) No cysts >10 mm Cysts are common in teens and ovarian size is largest at menarche. Norms in adolescents have NOT been established

24 Other Causes of PCOSlike Ovaries Normal women with normal ovulatory function (16%) Hyperprolactinaemia (50%) Hypothyroidism (36.4%) Hypogonadotrophic hypogonadism (23.7%) CAH (100%) Androgen-producing adrenal tumours Prevalence in PCOS (~ 53%) Abdel Gadir et al 92

25 Insulin Resistance in PCOS Increased insulin levels and decreased sensitivity amplify the hormonal features of PCOS. Treatment of insulin resistance may improve hyperandrogenism and even restore ovulation. May be tissue-specific, such that muscle/liver is resistant and ovary/adrenals are sensitive. Or pathway specific, with metabolic pathways resistant, and steroidogenic or mitogenic pathways sensitive Even in non-pcos women, IR can cause increased T but ovaries of PCOS women may be more sensitive

26 Insulin Effects in PCOS Stimulate ovarian theca cell androgenic pathways Augment LH-stimulated androgen secretion by induction of steroidogenic enzymes Lower hepatic SHBG production Alter hypothalamic LH regulation by GnRH Increase amplitude & frequency of LH pulses Enhance AMH to cause mid-antral follicular arrest Upregulate adrenal steroidogenic enzymes and sensitivity to ACTH

27 Jayasena CN et al. Nature Rev. Endo. 2014

28 Goals of PCOS Treatment Reduce production and effects of androgens Protect endometrium from prolonged estrogen Reduce weight and cardiometabolic risk with lifestyle changes Improve insulin sensitivity Restore fertility by inducing ovulatory cycles Treatment tailored to specific symptoms

29 Hormonal Treatment Oral contraceptives; mcg of ethinyl estradiol Some progestins less androgenic (cyproterone acetate*, drospirenone, desogestrel) but higher clot risk NIH guidelines: no specific recommendations, use any combined estrogen/progesterone contraceptive Contraindications: clot risk, migraine with aura, very high risk of breast/gyn cancer (BRCA positive, personal history) Medroxyprogesterone or progesterone for 7-10 days of each cycle (or every 3-4 months if no spontaneous menses) *not FDA-approved, due to concerns of hepatotoxicity

30 Effective even without IR Metformin Biguanide insulin sensitizer, inhibits hepatic GNG and increases peripheral glucose uptake Results INDEPENDENT of weight loss. Side effects: GI (common): nausea, diarrhea, gas (resolve with time) Vitamin B12 deficiency Lactic acidosis (negligible in non-dm) Titrate: start 500 mg/day and increase to max 2500 mg/day

31 Dermatologic Acne: topical treatments, antibiotics, retinoids Hirsutism: topical eflornithine (Vaniqa), slows growth Laser, electrolysis, waxing, shaving, depilatories, etc.. Even with androgen control, can only slow growth & prevent new growth already present follicles will not regress If considering permanent option, control androgens FIRST Alopecia: Minoxidil (Rogaine) to affected areas

32 Anti-androgens Spironolactone (competitive inhibitor of androgen receptor and inhibits 5a reductase); reduction in hirsutism and acne Monitor: K, BP Teratogenic! finasteride (5a reductase inhibitor) only blocks type 2 enzyme, and type 1 & 2 activated in PCOS; less effective for hirsutism Flutamide (non-steroidal anti-androgen) restore ovulation, reduce androgen. Risk of fatal hepatitis, anemia

33 Treatment Challenges in Teens Oral contraceptives: growth suppression social stigma (parents/child) side effects (mood, weight, headaches) compliance Metformin: side effects often not tolerated Effect takes time! Compliance even harder, twice a day!

34 Treatment Challenges in Teens Spironolactone: birth defects if pregnancy (feminization of male fetus) dizziness/orthostatic hypotension, high K Lifestyle interventions (diet/exercise): need family support financial barriers social barriers MOTIVATION

35 Is this normal? Back to our case NO, irregular menses >2 years post-menarche warrants evaluation Should it be evaluated? How? Laboratory testing for cause of symptoms (T, 17OHP, thyroid, gonadotropins, prolactin pregnancy test), metabolic screen if PCOS How can we counsel her, regardless of diagnosis? Lifestyle management for weight gain, psychological counseling for mood

36 Summary PCOS is common in teens, yet diagnosis may be challenging Clinical history and basic laboratory evaluation are sufficient for diagnosis in most cases Treatment is aimed at presenting symptoms and prevention of cardiometabolic disease Counseling on lifestyle modification (Nutrition) and regular metabolic screening are standard of care Screening for depression and other psychiatric disorders should also be done routinely

37 CHOP Endocrine PCOS Clinic Multidisciplinary, all pediatric providers Endocrinologist (Dr. Rachana Shah) Dermatologist (Dr. Marissa Perman) Nutritionist (Sarah Barnes, RD) Patients/families meet with multiple providers at one clinic visit to have all their needs met Laser hair removal offered through Dermatology; may be able to get insurance coverage

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION R A C H A N A S H A H, M D M S T R A S S I S TA N T P R O F E S S O R O F P E D I AT R I C S D I V I S I O N O F E N D O C R I N O L O G Y A N D D

More information

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic

More information

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman Polycystic Ovarian Syndrome (PCOS) for the Family Physician Barbara S. Apgar MD, MS Professor or Family Medicine University of Michigan Ann Arbor, Michigan Important references for PCOS Endocrine Society

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea

More information

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND 7% of all women 18-45 Obesity 1/3 of all US women Incidence of PCOS is increasing with increase obesity Obesity Irregular

More information

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO Dr Stella Milsom Endocrinologist Fertility Associates Auckland 12:30-12:40 When Puberty is PCO Puberty or Polycystic Ovary Syndrome? Stella Milsom Endocrinologist Auckland DHB, University of Auckland,

More information

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH 13 th Annual Women s Health Day PCOS Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH Learning objectives Perform the appropriate investigations in women where there is a clinical suspicion

More information

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about

More information

2-Hypertrichosis:- Hypertrichosis is the

2-Hypertrichosis:- Hypertrichosis is the Hirsutism And Virilization Hirsutism:- Is the development of androgen-dependent dependent terminal body hair in a woman in places in which terminal hair is normally not found, terminal body hairs are the

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome Polycystic Ovary Syndrome Kathleen Colleran, MD Professor of Medicine University of New Mexico HSC Presented for COMM-TC May 4, 2012 Objectives Understand the pathophysiology of PCOS Understand how to

More information

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions? Hirsutism Case 24 year old female presented to your office complaining of excess hair growth on her face and abdomen Questions? Started around puberty with gradual progression Irregular menstrual cycle

More information

Polycystic Ovary Syndrome (PCOS):

Polycystic Ovary Syndrome (PCOS): Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,

More information

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany) Hyperandrogenism Dr Jack Biko MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany) 2012 Hyperandrogenism Excessive production of androgens Adrenal glands main source

More information

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine

More information

Polycystic Ovarian Syndrome (PCOS) LOGO

Polycystic Ovarian Syndrome (PCOS) LOGO Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction

More information

PCOS and Obesity DUB is better treated by OCPs

PCOS and Obesity DUB is better treated by OCPs PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One

More information

Amenorrhoea: polycystic ovary syndrome

Amenorrhoea: polycystic ovary syndrome There is so much we don't know in medicine that could make a difference, and often we focus on the big things, and the little things get forgotten. To highlight some smaller but important issues, we've

More information

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

Prof.Dr. Nabil Lymon Head of Internal Medicine Department By Prof.Dr. Nabil Lymon Head of Internal Medicine Department Definitions: Hirsutism: Is the presence of terminal hair in androgendependent sites where hair does not normally grow in women. This hair growth

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome What is the polycystic ovary syndrome? Polycystic Ovary Syndrome The polycystic ovary syndrome (PCOS) is a clinical diagnosis characterized by the presence of two or more of the following features: irregular

More information

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W CASE #1 46 year old female presents with complaint of increased facial and abdominal hair growth for 6-8 months. She has had increased

More information

Abnormal Uterine Bleeding Case Studies

Abnormal Uterine Bleeding Case Studies Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead

More information

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018 POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018 PCOS: WHERE WE ARE AT IN 2018 Nancy Arquette, MD Premier Women s Health 6135 Trust Drive #114 Holland, OH 43528 February 3, 2018 Kalahari Resorts ME

More information

PCOS. Kirtly Parker Jones MD

PCOS. Kirtly Parker Jones MD PCOS Kirtly Parker Jones MD OBJECTIVES The participant will be able to use knowledge about ovarian physiology to council perimenarchal women about irregular periods The participant will be able to evaluate

More information

Female Reproductive Endocrinology

Female Reproductive Endocrinology Female Reproductive Endocrinology Dr. Channa Jayasena PhD MRCP FRCPath Clinical Senior Lecturer & Consultant Endocrinologist Department of Gynaecology, Hammersmith Hospital Anovulation is a common cause

More information

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA 16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA Katie O Sullivan, MD Adult/Pediatric Endocrinology Fellow University of Chicago ENDORAMA Thursday, September 4th, 2014 Disclosures No financial interests. Will

More information

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this... PCOS What is PCOS? You'll be amazed when you read this... What is PCOS?. Who is at risk? How to get tested? What are the complications. Is there a cure? What are the right ways to eat? What lifestyle changes

More information

Overview of Reproductive Endocrinology

Overview of Reproductive Endocrinology Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,

More information

What every dermatologist should know about Polycystic Ovary Syndrome (PCOS)

What every dermatologist should know about Polycystic Ovary Syndrome (PCOS) What every dermatologist should know about Polycystic Ovary Syndrome (PCOS) Kanade Shinkai, MD PhD University of California, San Francisco Associate Professor of Dermatology I have no conflicts of interest

More information

Polycystic Ovary Syndrome diagnosis & management

Polycystic Ovary Syndrome diagnosis & management Polycystic Ovary Syndrome diagnosis & management Dr Roisin Worsley, FRACP Endocrinologist, Jean Hailes at Epworth https://jeanhailes.org.au/contents/docume nts/resources/tools PCOS is a chronic condition

More information

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS PCOS Awareness Symposium Atlanta September 24 th, 2016 Preventing Diabetes & Cardiovascular Disease in PCOS Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome Polycystic Ovary Syndrome An Individualized Approach Alice Y. Chang, MD, MSc Assistant Professor Mayo Clinic Division of Endocrinology, Diabetes, Nutrition and Metabolism Learning Objectives: To Individualize

More information

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing

More information

New PCOS guidelines: What s relevant to general practice

New PCOS guidelines: What s relevant to general practice New PCOS guidelines: What s relevant to general practice Dr Michael Costello Fertility Specialist IVF Australia UNSW Royal Hospital for Women Sydney How do we know if something is new? Louvre Museum, Paris

More information

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia Precocious Puberty Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia Faculty Disclosure Faculty: Laura Stewart No relationships with

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is common. It can cause period problems, reduced fertility, excess hair growth, and acne. Many women with PCOS are also overweight. Treatment

More information

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist THE PILL Released to US market in 1960 10-15 x dose of hormones in HRT Over 10-14

More information

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guideline for the Investigation and Management of Polycystic Ovary Syndrome Author: Contact Name and Job Title

More information

By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.

By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS. PCOS & teens: The need for early detection By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC A 15-year-old girl is referred In this article: to the pediatric

More information

Disclosure. Outline. Obesity: Endocrine Issues as the Cause and as the Effect 4/5/2016

Disclosure. Outline. Obesity: Endocrine Issues as the Cause and as the Effect 4/5/2016 Obesity: Endocrine Issues as the Cause and as the Effect Angela Lennon MD Assistant Professor, Pediatrics University of Kansas Medical Center April 22, 2016 Disclosure I have no relevant financial relationships

More information

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University CREATING A PCOS TREATMENT PLAN Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University PCOS: CREATING A TREATMENT PLAN Good treatment plans are based on sound and complete evaluations History of

More information

Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG

Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG What is an ovulatory dysfunction? Mrs. Susana Godoy, Nurse-Midwife San José, Costa Rica Abril 2018 PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

More information

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the

More information

Objectives 1. Be able to describe the classic presentation and diagnostic criteria 2. Be able to explain long-term health concerns associated with the diagnosis 3. Understand what basic treatment options

More information

Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies

Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies 2017 Illinois-AACE 2017 Annual Meeting October 14, 2017 Learning Objectives 1) Understand the challenges

More information

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015 POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility Based on: ACOG No. 108 Oct 2009; reaffirmed 2015 NO DISCLOSURES PATIENT 26 years old presents with complaint of

More information

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji

More information

The Impact of Insulin Resistance on Long-Term Health in PCOS

The Impact of Insulin Resistance on Long-Term Health in PCOS Saturday, April 16 th, 2016 PCOS Challenge & Thomas Jefferson University PCOS Awareness Symposium Philadelphia The Impact of Insulin Resistance on Long-Term Health in PCOS Katherine Sherif, MD Professor

More information

PCOS guidelines: What s relevant to general practice

PCOS guidelines: What s relevant to general practice PCOS guidelines: What s relevant to general Dr David Molloy Medical Director, Queensland Fertility Group International evidence based PCOS guidelines 1st ever internationally endorsed & evidence based

More information

Difference Between PCOS and Endometriosis

Difference Between PCOS and Endometriosis Difference Between PCOS and Endometriosis www.differencebetween.com Key Difference PCOS vs Endometriosis Ovaries play an important role in the reproduction and the maintenance of the female body. They

More information

Reproductive Health and Pituitary Disease

Reproductive Health and Pituitary Disease Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives

More information

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is

More information

PCOS The intersection of sex hormones & metabolism. Educational Objectives. Presenter Disclosure Information. Polycystic Ovary Syndrome

PCOS The intersection of sex hormones & metabolism. Educational Objectives. Presenter Disclosure Information. Polycystic Ovary Syndrome 7:45 8:45 am Polycystic Ovary Syndrome: Diagnosis & Management SPEAKER Katherine Sherif, MD Presenter Disclosure Information The following relationships exist related to this presentation: Katherine Sherif,

More information

Polycystic ovary syndrome

Polycystic ovary syndrome Polycystic ovary syndrome Overview Polycystic ovary syndrome (PCOS) is a condition most often characterized by irregular menstrual periods, excess hair growth and obesity, but it can affect women in a

More information

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)

More information

F REQUENTLY A SKED Q UESTIONS

F REQUENTLY A SKED Q UESTIONS Polycystic heart, blood vessels, and appearance. Women with PCOS have these characteristics: Ovarian high levels of male hormones, also called androgens an irregular or no menstrual cycle Syndrome may

More information

OVERVIEW. FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1

OVERVIEW. FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1 OVERVIEW FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1 FEMM is a three-tiered women s healthcare project. Grounded in revolutionary, peer-reviewed research in

More information

S. AMH in PCOS Research Insights beyond a Diagnostic Marker

S. AMH in PCOS Research Insights beyond a Diagnostic Marker S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.

More information

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016 Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)

More information

Vol-4 No.-2 July-September 2011

Vol-4 No.-2 July-September 2011 "Women's Health" is also available at www.squarepharma.com.bd Vol-4 No.-2 July-September 2011 Editorial Board Dr. Omar Akramur Rab MBBS, FCGP, FIAGP Mohammad Hanif M. Pharm, MBA A.H.M.Rashidul Bari M.

More information

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY 1 SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR: SEX HORMONES PART 1 An Overview What are steroid hormones? Steroid

More information

Adolescent Gynecology: Evaluation and Management of Adnexal Mass, PCOS, and Endometriosis. Shanna M. Combs, MD

Adolescent Gynecology: Evaluation and Management of Adnexal Mass, PCOS, and Endometriosis. Shanna M. Combs, MD Adolescent Gynecology: Evaluation and Management of Adnexal Mass, PCOS, and Endometriosis Shanna M. Combs, MD Adolescent Visit and Exam Adolescent Reproductive Health Visit Initial visit should take place

More information

POLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives. Michel Abou Abdallah, MD. Reproductive Endocrinology

POLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives. Michel Abou Abdallah, MD. Reproductive Endocrinology POLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives Michel Abou Abdallah, MD. Reproductive Endocrinology At the conclusion of this presentation, participants should be able to: Appreciate the spectrum of

More information

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse

More information

Estrogen Dominant Conditions Part I

Estrogen Dominant Conditions Part I Estrogen Dominant Conditions Part I Why So Many Conditions? All estrogen dominant conditions have an imbalance of estrogen as part of the hormones issues the client has Different conditions have different

More information

Dr Mary Birdsall. Fertility Associates Auckland

Dr Mary Birdsall. Fertility Associates Auckland Dr Mary Birdsall Fertility Associates Auckland Period Problems Mary Birdsall Medical Director Fertility Associates Auckland Period Problems Basic Physiology No Periods Irregular Periods Heavy Periods

More information

Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy*

Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy* Gynecology-endocrinology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U S. A. Treatment of hirsutism with a gonadotropin-releasing hormone agonist

More information

Hormonal Treatment of Acne and Hirsutism. Julie C Harper MD

Hormonal Treatment of Acne and Hirsutism. Julie C Harper MD Hormonal Treatment of Acne and Hirsutism Julie C Harper MD none Conflict of Interest Androgen blockade Decrease androgen production by the gonads or adrenal gland Decrease circulating free testosterone

More information

Addressing Practice Gaps in PCOS

Addressing Practice Gaps in PCOS Addressing Practice Gaps in PCOS PCOS Challenge September 21, 2014 Ricardo Azziz, MD, MPH, MBA President, Georgia Regents University CEO, Georgia Regents Health System Introduction PCOS research began

More information

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline Kathryn A. Martin, 1 R. Rox Anderson, 1 R. Jeffrey Chang, 2 David

More information

Polycystic Ovary Syndrome: Cardiovascular Disease risk

Polycystic Ovary Syndrome: Cardiovascular Disease risk PCOS Challenge Atlanta September 16 th, 2017 Polycystic Ovary Syndrome: Cardiovascular Disease risk Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women s Primary

More information

Management of polycystic ovarian syndrome

Management of polycystic ovarian syndrome 14 Disorders of male and female sex hormones Management of polycystic ovarian syndrome LI-WEI CHO AND STEPHEN L. ATKIN Patients with polycystic ovarian syndrome can be challenging as they usually present

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome Page 1 of 5 Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is common. It can cause period problems, reduced fertility, excess hair growth, and acne. Many women with PCOS are also overweight.

More information

Reproductive physiology

Reproductive physiology Reproductive physiology Sex hormones: Androgens Estrogens Gestagens Learning objectives 86 (also 90) Sex Genetic sex Gonadal sex Phenotypic sex XY - XX chromosomes testes - ovaries external features Tha

More information

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital Touchdown to CME Eighth District Academy of Osteopathic Medicine & Surgery October 8. 2017 Goals

More information

About PCOS. About PCOS

About PCOS. About PCOS About PCOS About PCOS Polycystic Ovarian Syndrome (PCOS) is the most common hormonal reproductive problem in women of childbearing age. It can affect a woman s menstrual cycle, fertility, hormones, insulin

More information

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

Polycystic Ovary Disease: A Common Endocrine Disorder in Women Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University

More information

www.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc Conflict of interest none Outline Causes of ovulatory dysfunction Assessment of women with ovulatory dysfunction Management First line Second

More information

PUBERTY. Preetha Krishnamoorthy. Division of Pediatric Endocrinology

PUBERTY. Preetha Krishnamoorthy. Division of Pediatric Endocrinology PUBERTY Preetha Krishnamoorthy Division of Pediatric Endocrinology Case 1 8-year-old girl referred for breast development noted by mom What do you want to know? Normal or abnormal? What if this was an

More information

PedsCases Podcast Scripts

PedsCases Podcast Scripts PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Puberty and Pubertal Disorders Part 2: Precocious Puberty. These podcasts are designed to give medical students an overview

More information

Endocrine control of female reproductive function

Endocrine control of female reproductive function Medicine School of Women s & Children s Health Discipline of Obstetrics & Gynaecology Endocrine control of female reproductive function Kirsty Walters, PhD Fertility Research Centre, School of Women s

More information

From the editors desk

From the editors desk From the editors desk Dear all, We are happy to introduce the first issue of our magazine on hormonal health. This magazine will focus on updates related to common clinical problems in diabetes, thyroid,

More information

POLYCYSTIC OVARY SYNDROME INA S. IRABON,MD, FPOGS,FPSRM,FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY

POLYCYSTIC OVARY SYNDROME INA S. IRABON,MD, FPOGS,FPSRM,FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY POLYCYSTIC OVARY SYNDROME INA S. IRABON,MD, FPOGS,FPSRM,FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY TO DOWNLOAD LECTURE DECK MAIN REFERENCE Comprehensive Gynecology 7 th

More information

On Diseases Of Menstruation And Ovarian READ ONLINE

On Diseases Of Menstruation And Ovarian READ ONLINE On Diseases Of Menstruation And Ovarian READ ONLINE If you are searching for the ebook On Diseases of Menstruation and Ovarian in pdf format, in that case you come on to the right website. We present the

More information

INFERTILITY CAUSES. Basic evaluation of the female

INFERTILITY CAUSES. Basic evaluation of the female INFERTILITY Infertility is the inability to conceive after 12 months of unprotected intercourse. There are multiple causes of infertility and a systematic way to evaluate the condition. Let s look at some

More information

Hirsutism: Diagnosis and Treatment. Roger A. Lobo M.D. Columbia University

Hirsutism: Diagnosis and Treatment. Roger A. Lobo M.D. Columbia University Hirsutism: Diagnosis and Treatment Roger A. Lobo M.D. Columbia University Signs of hyperandrogenism Acne, Hirsutism, Alopecia All explained by increased androgen production and/or increased sensitivity

More information

GONADAL FUNCTION: An Overview

GONADAL FUNCTION: An Overview GONADAL FUNCTION: An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences Clinical Biochemistry BMLS III & BDS IV VJ Temple 1 What are the Steroid hormones?

More information

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm lactotrophs Hypothalamus GnRH 120 min- 60 min- LH Progesterone _ pituitary L H + Ovary + Estradiol +/- Uterus Antral follicle >2mm Ovulation Preovulatory follicles atresia Follicular phase Luteal phase

More information

Hormonal Control of Human Reproduction

Hormonal Control of Human Reproduction Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with

More information

DRAFT SUMMARY AND RECOMMENDATIONS OF International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018

DRAFT SUMMARY AND RECOMMENDATIONS OF International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018 DRAFT SUMMARY AND RECOMMENDATIONS OF International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018 For public consultation and will be submitted to NHMRC for

More information

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland Professor Paul Hofman Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland 14:00-14:55 WS #108: Common pubertal variants how to distinguish

More information

UPDATE: Women s Health Issues

UPDATE: Women s Health Issues UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial

More information

Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) Mr Nabil Haddad M. OBSTET, GYNAEC, FRCOG Consultant Gynaecologist Patient Information Polycystic Ovary Syndrome (PCOS) Mr Nabil Haddad Consultant Gynaecologist What is Polycystic Ovary Syndrome (PCOS)?

More information

Precocious Puberty. Disclosures. No financial disclosures 2/28/2019

Precocious Puberty. Disclosures. No financial disclosures 2/28/2019 Precocious Puberty Bracha Goldsweig, MD Pediatric Endocrinologist Children s Hospital and Medical Center, Omaha, NE University of Nebraska Medical Center Disclosures No financial disclosures 1 Objectives

More information

University of Cape Town

University of Cape Town P a g e 1 The Polycystic Ovary Syndrome a comparison of the presentation in adolescents compared to women aged 35 years and older attending the Gynaecological Endocrine clinic at Groote Schuur Hospital.

More information

OBJECTIVES. Rebecca McEachern, MD. Puberty: Too early, Too Late or Just Right? Special Acknowledgements. Maryann Johnson M.Ed.

OBJECTIVES. Rebecca McEachern, MD. Puberty: Too early, Too Late or Just Right? Special Acknowledgements. Maryann Johnson M.Ed. 1 Puberty: Too early, Too Late or Just Right? Maryann Johnson M.Ed., BSN, RN Special Acknowledgements Rebecca McEachern, MD OBJECTIVES Illustrate basic endocrine system and hormonal pathways Define the

More information

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN: Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex

More information

Infertility DR. RAHUL BEVARA

Infertility DR. RAHUL BEVARA Infertility DR. RAHUL BEVARA Definitions Infertility is defined as the inability to conceive after one year of unprotected coitus. Affects 10-15% of couples Primary Infertility, that is inability to conceive

More information

2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:

2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug: 2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: Name of Study Drug: Volume: Abbott-43818 (ABT-818) leuprolide acetate for depot suspension (Lupron Depot ) Name of

More information

Hirsutism - Management

Hirsutism - Management Hirsutism - Management Scenario: Diagnosis of hirsutism How do I know my patient has it? Look for excessive terminal hair in androgen-dependent areas including the face, chest, linea alba, lower back,

More information

Infertility for the Primary Care Provider

Infertility for the Primary Care Provider Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have

More information